Urinary beta2-microglobulin masquerading as a Bence Jones protein.

Area of Science:

• Hematology
• Clinical Chemistry
• Oncology

Background:

• Bence Jones proteinuria is a marker for multiple myeloma and other B-cell neoplasms, useful for diagnosis, staging, and monitoring therapy.
• Serum beta2-microglobulin levels are elevated in hematopoietic neoplasms and track tumor burden in multiple myeloma and lymphoproliferative disorders.
• Urinary beta2-microglobulin concentration reflects renal tubular function and can be elevated in tubular proteinuria, a complication of multiple myeloma.

Observation:

• A specific case highlighted an interference issue in laboratory testing.
• High urinary beta2-microglobulin levels were observed in the presented case.
• This elevation impacted the quantification of Bence Jones protein via electrophoresis.

Findings:

• Elevated urinary beta2-microglobulin can lead to inaccurate Bence Jones protein measurements.
• Electrophoresis, a common diagnostic tool, may yield false results due to this interference.
• The study underscores the importance of considering confounding factors in protein analysis.

Implications:

• Accurate quantification of Bence Jones protein is crucial for multiple myeloma diagnosis and treatment.
• Clinicians should be aware of potential interferences in laboratory assays.
• Further research may be needed to develop methods to mitigate such interferences for reliable patient management.